gallery/+++
gallery/+++
gallery/+++
gallery/login
gallery/login
gallery/zol111

An apple a day keeps the doctor away

Address:

227 Marion Street, Columbia, SC 29201

MedicPress

News

Health Jaka Jejčič February 16, 2017

All raw food must be washed well before eating or cooking. If someone had contracted the infection, he/she should not cook or serve food to others for at least three to four days after the symptom has cleared. Finally, remember to quarantine the sick person to prevent spread or reoccurrence.

Categories

MedicPress

×

Drugs.com - Pharma Industry Newshttps://www.drugs.com/pharmanews.html Headline news from Drugs.com. Comprehensive and up-to-date drug news for both consumers and healthcare professionals. enMonthly News Roundup - January 2018 https://www.drugs.com/news/monthly-news-roundup-january-2018-68555.html?utm_source=ddc&utm_medium=rss&utm_campaign=Monthly+News+Roundup+-+January+2018 Opdivo Gains New Adjuvant Use in Melanoma Adjuvant therapy can reduce the risk of cancer recurrence follow surgery that removes the tumor and lymph nodes. Bristol-Myers Squibb’s Opdivo (nivolumab) is now the first PD-1 inhibitor approved as... Wed, 31 Jan 2018 00:02:40 GMT FDA, FTC Warn Companies for Selling Illegal, Unapproved Opioid Cessation Products Using Deceptive Claims https://www.drugs.com/news/fda-ftc-warn-companies-selling-illegal-unapproved-opioid-cessation-products-using-deceptive-claims-68474.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA%2C+FTC+Warn+Companies+for+Selling+Illegal%2C+Unapproved+Opioid+Cessation+Products+Using+Deceptive+Claims January 24, 2018 -- The U.S. Food and Drug Administration and the Federal Trade Commission today posted joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims... Wed, 24 Jan 2018 21:01:23 GMTMonthly News Roundup - December 2017 https://www.drugs.com/news/monthly-news-roundup-december-2017-68229.html?utm_source=ddc&utm_medium=rss&utm_campaign=Monthly+News+Roundup+-+December+2017 Luxturna Gene Therapy OK’d for Rare Form of Vision Loss A historic approval, Luxturna (voretigene neparvovec-rzyl) from Spark Therapeutics is the first directly administered gene therapy that targets a disease caused by specific gene... Sun, 31 Dec 2017 22:12:26 GMT FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers https://www.drugs.com/news/fda-permits-marketing-device-diabetic-foot-ulcers-68228.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Permits+Marketing+of+Device+to+Treat+Diabetic+Foot+Ulcers Today, the Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. “Diabetes is the leading cause of lower limb amputations,” said Binita Ashar, M.D.,... Thu, 28 Dec 2017 06:12:01 GMT FDA Clears Stereotactic Radiotherapy System for Use in Treating Breast Cancer https://www.drugs.com/news/fda-clears-stereotactic-radiotherapy-treating-breast-cancer-68227.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Clears+Stereotactic+Radiotherapy+System+for+Use+in+Treating+Breast+Cancer December 22, 2017 -- Today, the U.S. Food and Drug Administration cleared a new noninvasive stereotactic radiotherapy system intended for use in treating cancer in breast tissue. “With today’s clearance, patients will have access to a treatment... Fri, 22 Dec 2017 05:12:49 GMT FDA Proposes New, Risk-Based Enforcement Priorities to Protect Consumers from Potentially Harmful, Unproven Homeopathic Drugs https://www.drugs.com/news/fda-proposes-new-risk-based-enforcement-priorities-protect-consumers-potentially-harmful-unproven-68114.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Proposes+New%2C+Risk-Based+Enforcement+Priorities+to+Protect+Consumers+from+Potentially+Harmful%2C+Unproven+Homeopathic+Drugs Today, the Food and Drug Administration proposed a new, risk-based enforcement approach to drug products labeled as homeopathic. To protect consumers who choose to use homeopathic products, this proposed new approach would update the FDA’s... Mon, 18 Dec 2017 20:12:16 GMT FDA Launches New Tool for Sharing Information That Allows Doctors to Better Manage Antibiotic Use https://www.drugs.com/news/fda-launches-new-tool-sharing-allows-doctors-better-manage-antibiotic-68064.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Launches+New+Tool+for+Sharing+Information+That+Allows+Doctors+to+Better+Manage+Antibiotic+Use Today the Food and Drug Administration is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care professionals as part of an overall effort to combat antimicrobial resistance. The agency created a... Wed, 13 Dec 2017 19:12:21 GMT FDA Warns Companies for Promoting Alternatives to Street Drugs https://www.drugs.com/news/fda-warns-companies-promoting-alternatives-street-68049.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Warns+Companies+for+Promoting+Alternatives+to+Street+Drugs December 12, 2017 -- The U.S. Food and Drug Administration today posted a warning letter to the marketers and distributors of Legal Lean Syrup, a drink, and Coco Loko, a “snortable” chocolate powder, for selling unapproved new drugs and... Tue, 12 Dec 2017 19:12:58 GMTMonthly News Roundup - November 2017 https://www.drugs.com/news/monthly-news-roundup-november-2017-67924.html?utm_source=ddc&utm_medium=rss&utm_campaign=Monthly+News+Roundup+-+November+2017 FDA Approves Juluca, a Novel 2-Drug Regimen for HIV-1 Infection In November, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare’s Juluca (dolutegravir and rilpivirine), a single-tablet, two-drug regimen of dolutegravir... Thu, 30 Nov 2017 22:11:55 GMT FDA Grants Marketing Authorization of the First Device for Use in Helping to Reduce the Symptoms of Opioid Withdrawal https://www.drugs.com/news/fda-grants-marketing-authorization-first-device-helping-reduce-opioid-67770.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Grants+Marketing+Authorization+of+the+First+Device+for+Use+in+Helping+to+Reduce+the+Symptoms+of+Opioid+Withdrawal November 15, 2017 -- Today, the U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal. “Given the scope of the epidemic of opioid addiction, we... Wed, 15 Nov 2017 23:11:33 GMT FDA Warns Companies Marketing Unproven Products, Derived From Marijuana, that Claim to Treat or Cure Cancer https://www.drugs.com/news/fda-warns-companies-marketing-unproven-products-derived-marijuana-claim-cure-cancer-67634.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Warns+Companies+Marketing+Unproven+Products%2C+Derived+From+Marijuana%2C+that+Claim+to+Treat+or+Cure+Cancer November 1, 2017 -- As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency today issued warning letters to four companies illegally selling products online that claim to prevent,... Wed, 01 Nov 2017 20:11:52 GMTMonthly News Roundup - October 2017 https://www.drugs.com/news/monthly-news-roundup-october-2017-67580.html?utm_source=ddc&utm_medium=rss&utm_campaign=Monthly+News+Roundup+-+October+2017 Yescarta CAR T-Cell Therapy Approved for Lymphoma Novel chimeric antigen receptor T cell (CAR T) therapy allows patients with certain blood cancers -- but limited treatment options -- to achieve remission. The U.S. Food and Drug Administration... Tue, 31 Oct 2017 22:10:00 GMTMonthly News Roundup - September 2017 https://www.drugs.com/news/monthly-news-roundup-september-2017-67213.html?utm_source=ddc&utm_medium=rss&utm_campaign=Monthly+News+Roundup+-+September+2017 FDA Approves Lilly’s Verzenio: Targeted Breast Cancer Treatment Lilly’s Verzenio (abemaciclib), a CDK 4/6 inhibitor breast cancer treatment, has been FDA-approved. Verzenio is used in 2 patient populations: either with fulvestrant (Faslodex)... Sat, 30 Sep 2017 21:09:12 GMT FDA Improves Access to Reports of Adverse Drug Reactions https://www.drugs.com/news/fda-improves-access-reports-adverse-reactions-67211.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Improves+Access+to+Reports+of+Adverse+Drug+Reactions September 28, 2017 -- The U.S. Food and Drug Administration today launched a new user-friendly search tool that improves access to data on adverse events associated with drug and biologic products through the FDA’s Adverse Event Reporting System... Thu, 28 Sep 2017 05:10:05 GMT FDA Approves First Continuous Glucose Monitoring System for Adults Not Requiring Blood Sample Calibration https://www.drugs.com/news/fda-approves-first-continuous-glucose-monitoring-adults-not-requiring-blood-sample-calibration-67210.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Approves+First+Continuous+Glucose+Monitoring+System+for+Adults+Not+Requiring+Blood+Sample+Calibration September 27, 2017 -- The U.S. Food and Drug Administration today approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions... Wed, 27 Sep 2017 05:10:15 GMT FDA Conducts Major Global Operation to Protect Consumers From Potentially Dangerous Prescription Drugs Sold Online https://www.drugs.com/news/fda-conducts-major-global-operation-protect-consumers-potentially-dangerous-sold-online-67139.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Conducts+Major+Global+Operation+to+Protect+Consumers+From+Potentially+Dangerous+Prescription+Drugs+Sold+Online September 25, 2017 -- The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, recently took action against more than 500 websites that illegally sell potentially dangerous, unapproved... Mon, 25 Sep 2017 20:09:58 GMT Teva Announces Reintroduction of Generic Depo-Provera in the United States https://www.drugs.com/news/teva-announces-reintroduction-depo-provera-united-states-67176.html?utm_source=ddc&utm_medium=rss&utm_campaign=Teva+Announces+Reintroduction+of+Generic+Depo-Provera+in+the+United+States JERUSALEM--(BUSINESS WIRE)--Sep. 25, 2017-- Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the reintroduction of the generic equivalent to Depo-Provera1 Contraceptive Injection (medroxyprogesterone acetate injectable suspension,... Mon, 25 Sep 2017 01:09:52 GMT Criminal and Civil Actions Filed Against Aegerion Pharmaceuticals Inc. https://www.drugs.com/news/criminal-civil-actions-filed-against-aegerion-pharmaceuticals-inc-67138.html?utm_source=ddc&utm_medium=rss&utm_campaign=Criminal+and+Civil+Actions+Filed+Against+Aegerion+Pharmaceuticals+Inc. September 22, 2017 -- Today, Aegerion Pharmaceuticals Inc. agreed to plead guilty in the United States District Court for the District of Massachusetts to two misdemeanor counts of violating the Federal Food, Drug, and Cosmetic Act (FD&C Act)... Fri, 22 Sep 2017 20:09:39 GMTMonthly News Roundup - August 2017 https://www.drugs.com/news/monthly-news-roundup-august-2017-66871.html?utm_source=ddc&utm_medium=rss&utm_campaign=Monthly+News+Roundup+-+August+2017 Kymriah from Novartis Approved as First U.S. CAR-T Cell Therapy History was made this month as the U.S. Food and Drug Administration (FDA) approved the first U.S. cell-based gene therapy known collectively as chimeric antigen receptor (CAR)... Thu, 31 Aug 2017 23:08:10 GMT FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection https://www.drugs.com/news/fda-provides-new-tools-development-proper-evaluation-tests-detecting-zika-virus-infection-66728.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+provides+new+tools+for+the+development+and+proper+evaluation+of+tests+for+detecting+Zika+virus+infection August 17, 2017 -- As an additional measure in the fight against Zika virus, today the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to... Thu, 17 Aug 2017 21:08:20 GMT FDA Warns of Potential Contamination in Multiple Brands of Drugs, Dietary Supplements https://www.drugs.com/news/fda-warns-potential-contamination-multiple-brands-dietary-supplements-66649.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Warns+of+Potential+Contamination+in+Multiple+Brands+of+Drugs%2C+Dietary+Supplements August 11, 2017 -- The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby... Fri, 11 Aug 2017 21:08:20 GMTMonthly News Roundup - July 2017 https://www.drugs.com/news/monthly-news-roundup-july-2017-66491.html?utm_source=ddc&utm_medium=rss&utm_campaign=Monthly+News+Roundup+-+July+2017 FDA Approves Gilead’s Vosevi for Six Hepatitis C Genotypes The U.S. Food and Drug Administration (FDA) has approved Gilead’s Vosevi (sofosbuvir, velpatasvir and voxilaprevir) for retreatment of adults with chronic hepatitis C virus (HCV) of... Mon, 31 Jul 2017 04:07:10 GMT FDA Clears First Neonatal Magnetic Resonance Imaging Device https://www.drugs.com/news/fda-clears-first-neonatal-magnetic-resonance-imaging-device-66410.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Clears+First+Neonatal+Magnetic+Resonance+Imaging+Device July 20, 2017 -- Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU). “Although we can use traditional MRI... Thu, 20 Jul 2017 22:07:07 GMTEndo Provides Update On Opana ER https://www.drugs.com/news/endo-provides-update-opana-er-66239.html?utm_source=ddc&utm_medium=rss&utm_campaign=Endo+Provides+Update+On+Opana+ER DUBLIN, July 6, 2017 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) continues to believe in the safety, efficacy, and favorable benefit-risk profile of Opana ER (oxymorphone hydrochloride extended release) when used as intended, and notes... Thu, 06 Jul 2017 03:07:27 GMT FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy https://www.drugs.com/news/fda-clears-expanded-cooling-cap-reduce-hair-loss-during-chemotherapy-66206.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Clears+Expanded+Use+of+Cooling+Cap+to+Reduce+Hair+Loss+During+Chemotherapy July 3, 2017 -- Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in... Mon, 03 Jul 2017 06:07:35 GMTMonthly News Roundup - June 2017 https://www.drugs.com/news/monthly-news-roundup-june-2017-66154.html?utm_source=ddc&utm_medium=rss&utm_campaign=Monthly+News+Roundup+-+June+2017 New Fluoroquinolone Baxdela Approved for Certain Skin Infections Roughly 3 million patients are hospitalized each year in the U.S. with acute bacterial skin and skin structure infections (ABSSSIs), some of which may be difficult-to-treat and... Fri, 30 Jun 2017 03:06:43 GMT FDA Allows Marketing of Test to Aid in the Detection of Certain Leukemias and Lymphomas https://www.drugs.com/news/fda-allows-marketing-test-aid-detection-certain-leukemias-lymphomas-66205.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Allows+Marketing+of+Test+to+Aid+in+the+Detection+of+Certain+Leukemias+and+Lymphomas June 29, 2017 -- The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas,... Thu, 29 Jun 2017 06:07:16 GMT FDA Unveils Plan to Eliminate Orphan Designation Backlog https://www.drugs.com/news/fda-unveils-plan-eliminate-orphan-designation-backlog-66204.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Unveils+Plan+to+Eliminate+Orphan+Designation+Backlog June 29, 2017 -- Today, the U.S. Food and Drug Administration unveiled a strategic plan to eliminate the agency’s existing orphan designation request backlog and ensure continued timely response to all new requests for designation with firm... Thu, 29 Jun 2017 05:07:24 GMT FDA Tackles Drug Competition to Improve Patient Access https://www.drugs.com/news/fda-tackles-competition-improve-patient-access-66203.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Tackles+Drug+Competition+to+Improve+Patient+Access June 27, 2017 -- Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent,... Tue, 27 Jun 2017 04:07:11 GMT Sonar Products Ordered to Cease Operations, Stratus Pharmaceuticals Ordered to Cease Distributing Unapproved Drugs https://www.drugs.com/news/sonar-products-ordered-cease-operations-stratus-pharmaceuticals-ordered-cease-distributing-66202.html?utm_source=ddc&utm_medium=rss&utm_campaign=Sonar+Products+Ordered+to+Cease+Operations%2C+Stratus+Pharmaceuticals+Ordered+to+Cease+Distributing+Unapproved+Drugs June 15, 2017 -- Today, U.S. District Judge Kathleen M. Williams for the Southern District of Florida entered a consent decree of permanent injunction between the United States and Stratus Pharmaceuticals Inc. of Miami, Florida, Sonar Products Inc.... Thu, 15 Jun 2017 04:07:56 GMT FDA Requests Removal of Opana ER for Risks Related to Abuse https://www.drugs.com/news/fda-requests-removal-opana-er-risks-related-abuse-65892.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Requests+Removal+of+Opana+ER+for+Risks+Related+to+Abuse June 8, 2017 -- Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is... Thu, 08 Jun 2017 21:06:27 GMT FDA Approves First Generic Truvada for HIV Infection and Pre-Exposure Prophylaxis (PrEP) https://www.drugs.com/news/fda-approves-first-truvada-hiv-infection-pre-exposure-prophylaxis-prep-65947.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Approves+First+Generic+Truvada+for+HIV+Infection+and+Pre-Exposure+Prophylaxis+%28PrEP%29 June 8, 2017 - The U.S. Food and Drug Administration has approved the first generic version of Truvada for the treatment of HIV-1, in combination with other antiretroviral agents, and for pre-exposure prophylaxis (PrEP) in combination with safer sex... Thu, 08 Jun 2017 04:06:33 GMTMonthly News Roundup - May 2017 https://www.drugs.com/news/monthly-news-roundup-may-2017-65774.html?utm_source=ddc&utm_medium=rss&utm_campaign=Monthly+News+Roundup+-+May+2017 Actemra: First Drug Approved to Treat Giant Cell Arteritis Actemra (tocilizumab) from Hoffman La Roche has gained a new indication as the first drug approved to treat adults with giant cell arteritis, a specific type of vasculitis. Vasculitis is... Tue, 30 May 2017 22:05:17 GMT FDA Approves First Generic Strattera for the Treatment of ADHD https://www.drugs.com/news/fda-approves-first-strattera-adhd-65771.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Approves+First+Generic+Strattera+for+the+Treatment+of+ADHD May 30, 2017 -- The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients. Apotex Inc., Teva Pharmaceuticals... Tue, 30 May 2017 11:05:39 GMT FDA Warns Americans About Risk of Inaccurate Results from Certain Lead Tests https://www.drugs.com/news/fda-warns-americans-risk-inaccurate-results-certain-lead-tests-65624.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Warns+Americans+About+Risk+of+Inaccurate+Results+from+Certain+Lead+Tests May 17, 2017 -- The U.S. Food and Drug Administration and Centers for Disease Control and Prevention are warning Americans that certain lead tests manufactured by Magellan Diagnostics may provide inaccurate results for some children and adults in... Wed, 17 May 2017 17:05:13 GMT FDA Authorizes Use of New Device to Treat Esophageal Birth Defect in Babies https://www.drugs.com/news/fda-authorizes-new-device-esophageal-birth-defect-babies-65571.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Authorizes+Use+of+New+Device+to+Treat+Esophageal+Birth+Defect+in+Babies May 12, 2017 -- The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their... Fri, 12 May 2017 13:05:09 GMTMonthly News Roundup - April 2017 https://www.drugs.com/news/monthly-news-roundup-april-2017-65393.html?utm_source=ddc&utm_medium=rss&utm_campaign=Monthly+News+Roundup+-+April+2017 Takeda Announces FDA Accelerated Approval of Alunbrig The US Food and Drug Administration (FDA) has approved once-daily oral Alunbrig (brigatinib) for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small... Sun, 30 Apr 2017 02:04:34 GMT FDA Approves Two Hepatitis C Drugs - Sovaldi and Harvoni - for Pediatric Patients https://www.drugs.com/news/fda-approves-two-hepatitis-c-sovaldi-harvoni-pediatric-patients-65133.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Approves+Two+Hepatitis+C+Drugs+-+Sovaldi+and+Harvoni+-+for+Pediatric+Patients April 7, 2017 -- The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were... Fri, 07 Apr 2017 11:05:01 GMT FDA Allows Marketing of First Direct-to-Consumer Tests that Provide Genetic Risk Information for Certain Conditions https://www.drugs.com/news/fda-allows-marketing-first-direct-consumer-tests-provide-genetic-risk-certain-conditions-65116.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Allows+Marketing+of+First+Direct-to-Consumer+Tests+that+Provide+Genetic+Risk+Information+for+Certain+Conditions April 6, 2017 -- The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer (DTC) tests authorized by the FDA... Thu, 06 Apr 2017 22:04:39 GMT FDA Alerts Consumers of Nationwide Voluntary Recall of EpiPen and EpiPen Jr https://www.drugs.com/news/fda-alerts-consumers-nationwide-voluntary-recall-epipen-epipen-jr-65046.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Alerts+Consumers+of+Nationwide+Voluntary+Recall+of+EpiPen+and+EpiPen+Jr March 31, 2017 -- The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency... Fri, 31 Mar 2017 23:03:40 GMT
gallery/medicpress-wp-content-uploads-sites-48-2017-02-photo12

Research Jaka Jejčič February 16, 2017

Located in the heart of the city,MedicPress is a state-of-the-art medical center which is striving towards its commitment to provide comprehensive health care services to the residents as well as any patient walking in at the most affordable cost.

gallery/medicpress-wp-content-uploads-sites-48-2017-02-photo4

With the hospital founder as a leading cardiac surgeon, MedicPress has been able to establish itself as the ultimate destination for diagnosis, treatment, and prevention of all kinds of heart and vascular diseases and their treatment. Here, almost all types of cardiovascular disorders are treated including coronary heart disease, arrhythmia, heart muscle disease, heart failure, heart valve disease, peripheral vascular disease and all kind of defects.

gallery/medicpress-wp-content-uploads-sites-48-2017-02-photo52

Stress is also known to cause hyperarousal, a medical state when a stressed person does not feel sleepy. If the symptoms persist for a long time, this insomnia leads to severe sleep disorders. Let’s see some of the effects stress can have on the body.

gallery/medicpress-wp-content-uploads-sites-48-2017-02-photo7

Health Jaka Jejčič February 16, 2017

Open 24/7; patients are encouraged to book appointments with us at their own convenient time and spend the minimum time waiting. We pride ourselves on our prompt service. Experience our service and care once, and we are confident of becoming your exclusive choice.

Irrespective of stress being a short-term frustration or arising from a major catastrophic event in life like death, divorce, etc., it can influence the body to a surprising level. Let’s see some of the effects stress can have on the body.

gallery/medicpress-wp-content-uploads-sites-48-2017-02-photo45

Even though stomach flu or acute gastroenteritis is commonly benign and self-limited and subsides within a few days; it can knock you out for a few days and leave you extremely tired and weak. With your intestines attacked by the flu, one often manifests symptoms like nausea, vomiting, diarrhoea and even mild fever.

gallery/data-5edb31ffca9a562556b1ae6b94c6bcd9

Irrespective of stress being a short-term frustration or arising from a major catastrophic event in life like death, divorce, etc., it can influence the body to a surprising level. Let’s see some of the effects stress can have on the body.

Overproduction of cortisol hormone increases your sugar and fat cravings and leads you to have a larger portion of food. This phenomenon is called ‘emotional eating’. This also affects the metabolism and digestion of food. Consequently, one finds a severe weight gain and thus opens the door to various other diseases.

gallery/medicpress-wp-content-uploads-sites-48-2017-02-photo44

Health Jaka Jejčič February 16, 2017

With the hospital founder as a leading cardiac surgeon, MedicPresshas been able to establish itself as the ultimate destination for diagnosis, treatment, and prevention of all kinds of heart and vascular diseases and their treatment.

1

Amazing WordPress
Themes!

View our themes here.

Recent Posts

Departments

Menu